PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
2.37%
Revenue growth under 50% of MCHP's 10.82%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
-7.67%
Negative gross profit growth while MCHP is at 15.09%. Joel Greenblatt would examine cost competitiveness or demand decline.
-217.14%
Negative EBIT growth while MCHP is at 140.04%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-217.14%
Negative operating income growth while MCHP is at 132.00%. Joel Greenblatt would press for urgent turnaround measures.
-190.74%
Negative net income growth while MCHP stands at 87.97%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-160.00%
Negative EPS growth while MCHP is at 70.34%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-160.00%
Negative diluted EPS growth while MCHP is at 70.34%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.49%
Share reduction while MCHP is at 0.33%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.49%
Reduced diluted shares while MCHP is at 0.33%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
402.45%
Dividend growth above 1.5x MCHP's 10.17%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
-59.18%
Negative OCF growth while MCHP is at 33.85%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
0.93%
FCF growth under 50% of MCHP's 34.43%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
30.70%
10Y revenue/share CAGR at 50-75% of MCHP's 51.09%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
30.70%
Positive 5Y CAGR while MCHP is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
8.56%
Positive 3Y CAGR while MCHP is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1331.05%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-1331.05%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-271.58%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
857.05%
10Y dividend/share CAGR above 1.5x MCHP's 180.63%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
857.05%
5Y dividend/share CAGR above 1.5x MCHP's 175.02%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
786.16%
3Y dividend/share CAGR above 1.5x MCHP's 81.65%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
6.53%
AR growth well above MCHP's 10.99%. Michael Burry fears inflated revenue or higher default risk in the near future.
-4.17%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-1.07%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-13.85%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
19.44%
We have some new debt while MCHP reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
16.77%
SG&A growth well above MCHP's 4.80%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.